BlackRock’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84B Buy
6,574,261
+129,405
+2% +$34M 0.03% 469
2026
Q1
$1.72B Sell
6,444,856
-95,925
-1% -$26M 0.03% 460
2025
Q4
$1.64B Sell
6,540,781
-1,584,752
-20% -$421M 0.03% 481
2025
Q3
$2.33B Sell
8,125,533
-936,667
-10% -$251M 0.04% 361
2025
Q2
$2.38B Sell
9,062,200
-215,313
-2% -$52.4M 0.05% 341
2025
Q1
$2.16B Sell
9,277,513
-43,610
-0.5% -$10.6M 0.05% 349
2024
Q4
$2.14B Buy
9,321,123
+169,591
+2% +$38.9M 0.04% 368
2024
Q3
$2.05B Sell
9,151,532
-341,612
-4% -$75.1M 0.04% 374
2024
Q2
$1.93B Buy
9,493,144
+58,885
+0.6% +$12M 0.04% 368
2024
Q1
$2.06B Sell
9,434,259
-1,054,738
-10% -$232M 0.05% 357
2023
Q4
$2.38B Sell
10,488,997
-1,386,222
-12% -$291M 0.06% 295
2023
Q3
$2.39B Sell
11,875,219
-2,912,161
-20% -$614M 0.07% 276
2023
Q2
$3.07B Buy
14,787,380
+865,811
+6% +$168M 0.08% 222
2023
Q1
$2.74B Buy
13,921,569
+564,938
+4% +$116M 0.08% 245
2022
Q4
$2.7B Buy
13,356,631
+44,665
+0.3% +$8.73M 0.08% 235
2022
Q3
$2.34B Buy
13,311,966
+293,465
+2% +$60.1M 0.08% 246
2022
Q2
$2.62B Buy
13,018,501
+1,871,130
+17% +$399M 0.08% 229
2022
Q1
$2.53B Buy
11,147,371
+1,515,958
+16% +$357M 0.07% 286
2021
Q4
$2.6B Buy
9,631,413
+610,609
+7% +$151M 0.07% 289
2021
Q3
$2.18B Sell
9,020,804
-104,516
-1% -$26.3M 0.06% 314
2021
Q2
$2.16B Sell
9,125,320
-284,395
-3% -$64.8M 0.06% 319
2021
Q1
$2.06B Buy
9,409,715
+292,609
+3% +$58.7M 0.06% 315
2020
Q4
$1.59B Sell
9,117,106
-858
-0% -$148K 0.05% 363
2020
Q3
$1.47B Sell
9,117,964
-134,518
-1% -$21.3M 0.05% 332
2020
Q2
$1.32B Sell
9,252,482
-1,052,092
-10% -$146M 0.05% 341
2020
Q1
$1.12B Sell
10,304,574
-3,464
-0% -$499K 0.05% 325
2019
Q4
$1.5B Sell
10,308,038
-110,685
-1% -$16M 0.06% 326
2019
Q3
$1.5B Buy
10,418,723
+5,942
+0.1% +$867K 0.06% 293
2019
Q2
$1.55B Sell
10,412,781
-1,261,308
-11% -$176M 0.07% 285
2019
Q1
$1.53B Buy
11,674,089
+299,349
+3% +$36.9M 0.07% 270
2018
Q4
$1.23B Buy
11,374,740
+736,935
+7% +$98.7M 0.06% 300
2018
Q3
$1.59B Buy
10,637,805
+497,861
+5% +$75.7M 0.07% 275
2018
Q2
$1.56B Buy
10,139,944
+848,600
+9% +$128M 0.07% 266
2018
Q1
$1.29B Buy
9,291,344
+13,249
+0.1% +$1.95M 0.06% 313
2017
Q4
$1.27B Buy
9,278,095
+185,820
+2% +$24.6M 0.06% 318
2017
Q3
$1.18B Buy
9,092,275
+96,853
+1% +$12.9M 0.06% 320
2017
Q2
$1.19B Sell
8,995,422
-403,154
-4% -$49.4M 0.06% 309
2017
Q1
$1.16B Buy
9,398,576
+9,144,730
+3,602% +$1.08B 0.06% 308
2016
Q4
$28M Sell
253,846
-20,626
-8% -$2.29M 0.04% 462
2016
Q3
$32.4M Buy
274,472
+3,779
+1% +$445K 0.05% 425
2016
Q2
$30.3M Sell
270,693
-4,333
-2% -$466K 0.05% 420
2016
Q1
$27.7M Sell
275,026
-37,579
-12% -$3.6M 0.04% 414
2015
Q4
$33.2M Buy
312,605
+5,728
+2% +$591K 0.05% 403
2015
Q3
$28.6M Buy
306,877
+15,826
+5% +$1.64M 0.04% 409
2015
Q2
$30.3M Sell
291,051
-54,679
-16% -$5.69M 0.04% 410
2015
Q1
$37.5M Buy
345,730
+106,584
+45% +$11M 0.05% 384
2014
Q4
$22.2M Buy
239,146
+13,993
+6% +$1.24M 0.03% 497
2014
Q3
$19.7M Sell
225,153
-34,066
-13% -$3.08M 0.03% 521
2014
Q2
$22.8M Buy
259,219
+901
+0.3% +$78K 0.03% 474
2014
Q1
$21.8M Sell
258,318
-5,512
-2% -$440K 0.04% 483
2013
Q4
$20.7M Buy
263,830
+2,518
+1% +$215K 0.03% 485
2013
Q3
$22.3M Buy
261,312
+2,767
+1% +$233K 0.04% 425
2013
Q2
$22.2M Buy
+258,545
New +$21.5M 0.04% 404

Other funds holding LH

BlackRock's LH Position: Q2 2026 in Review

BlackRock increased its Labcorp (LH) stake by 2% in Q2 2026, buying an estimated $34M and bringing the position to 6,574,261 shares worth $1.84B. The position accounts for 0.03% of the portfolio, ranked #469.

BlackRock first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.07B in Q2 2023. 1,054 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • BlackRock held 6,574,261 shares of Labcorp worth $1.84B as of Q2 2026.
  • BlackRock bought 129,405 Labcorp shares in Q2 2026, an estimated $34M.
  • Labcorp made up 0.03% of BlackRock's portfolio in Q2 2026, its #469 holding.
  • BlackRock first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Labcorp position peaked at $3.07B in Q2 2023.
  • 1,054 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.